Epidemiological studies suggest that aflatoxin B 1 (AFB 1 ), a mycotoxin produced by certain Aspergillus species, may play a role in human respiratory cancers in occupationallyexposed individuals. AFB 1 requires bioactivation to the corresponding exo-8,9-epoxide for carcinogenicity, and glutathione S-transferase (GST)-catalyzed conjugation of the epoxide with glutathione (GSH) is a critical determinant of susceptibility to AFB 1 . Of the purified human GST enzymes studied, the polymorphic hGSTM1-1 has the highest activity towards AFB 1 exo-epoxide. The influence of the GSTM1 polymorphism on AFB 1 -GSH formation, as well as the abilities of cytosols from preparations enriched in different isolated lung cell types to conjugate AFB 1 -epoxides, were examined. In whole-lung cytosols from patients undergoing clinically indicated lobectomy, GSTM1 genotype correlated with GSTM1 phenotype as determined by [ 3 H]trans-stilbene oxide conjugation: GSTM1-positive ⍧ 295 Ϯ 31 pmol/mg/h (n ⍧ 6); GSTM1-negative ϭ 92.8 ⍨ 23.3 pmol/mg/h (n ⍧ 4) (P < 0.05). In contrast, conjugation of microsome-generated [ 3 H]AFB 1 -epoxides with GSH was low and variable between patients, and did not correlate with GSTM1 genotype: GSTM1-positive ⍧ 11.9 ⍨ 8.1, 111 ⍨ 66 and 510 ⍨ 248 fmol/mg/h (n ⍧ 6); GSTM1-negative ⍧ 15.3 ⍨ 16.7, 167 ⍨ 225 and 540 ⍨ 618 fmol/mg/h (n ⍧ 4) (for 1, 10 and 100 µM [ 3 H]AFB 1 , respectively). GSH conjugates of AFB 1 exo-epoxide and the much less mutagenic stereoisomer AFB 1 endo-epoxide were produced in a ratio of~1:1 in cytosols from both whole lung and isolated cells. Total cytosolic AFB 1 -epoxide conjugation was significantly higher in fractions enriched in alveolar type II cells (3.07 ⍨ 1.61 pmol/mg/h) than in unseparated lung cells (0.143 ⍨ 0.055 pmol/mg/h) or fractions enriched in alveolar macrophages (0.904 ⍨ 0.319 pmol/mg/h; n ⍧ 4) (P < 0.05). Furthermore, AFB 1 -GSH formation and percentage of alveolar type II cells in different cell fractions were correlated (r ⍧ 0.78, P < 0.05). These results demonstrate that human lung GSTs exhibit very low conjugation activity for both AFB 1 -8,9-epoxide stereoisomers, and that this activity is heterogeneously Abbreviations: AFB 1 , aflatoxin B 1 ; CDNB, 1-chloro-2,4-dinitrobenzene; EDTA, ethylenediaminetetraacetic acid; GSH, glutathione; GST, glutathione S-transferase; HEPES, N-2-hydroxy-ethylpiperazine-N-2-ethanesulfonic acid; HPLC, high-performance liquid chromatography; PCR, polymerase chain reaction; tSBO, trans-stilbene oxide.
Introduction
Aflatoxin B 1 (AFB 1 ) is a cytotoxic and carcinogenic mycotoxin produced by strains of the fungus Aspergillus flavus and related species. These fungi are ubiquitous, and under favourable conditions can grow on a wide variety of agricultural commodities. Though the liver is considered the primary target of AFB 1 toxicity, the human lung can be exposed to AFB 1 through inhalation of respirable contaminated grain dusts (1) . In certain agriculture-related occupational settings, such exposure has been implicated in respiratory cancer (2) and liver cancer (3) , and clinical studies have revealed AFB 1 -albumin adducts in the sera of animal feed processing workers (4) . Additionally, AFB 1 and/or metabolites have been found in lung tumour tissues of workers who died of lung carcinoma (5, 6) . The presence of DNA adducts suggests that the human lung also may be at risk of AFB 1 toxicity after ingestion of contaminated foods (7, 8) .
For toxicity to occur, AFB 1 requires bioactivation to exo and endo stereoisomers of AFB 1 -8,9-epoxide, although only AFB 1 exo-epoxide binds appreciably to DNA (9) . Glutathione S-transferases (GSTs) catalyze conjugation of AFB 1 -8,9-epoxides with reduced glutathione (GSH) to form AFB 1 exoand endo-epoxide-GSH conjugates ( Figure 1 ). Thus, GSTs play a critical role in the protection of tissues from the deleterious effects of bioactivated AFB 1 (10) , and tissues vary considerably in both GST concentration and distribution of specific GST isoforms (11) .
In humans, the GST with the highest activity toward AFB 1 exo-epoxide is the polymorphic hGSTM1-1 (12, 13) , which is absent in~50% of individuals in most human populations (14) . This suggests that AFB 1 -exposed individuals lacking the beneficial effects of hGSTM1-1 may be at elevated risk. Indeed, some reports suggest that the GSTM1 genetic polymorphism may affect AFB 1 detoxification in human liver (15, 16) . In contrast to the liver, the lung is composed of many different cell types (17) , and expression of GSTs in different human lung cell types is heterogeneous (18) (19) (20) . Thus, certain cell types with low levels of GSTs or lacking specific GST isoforms may be at higher risk of AFB 1 toxicity. In the present study, the abilities of GSTs in peripheral human lung to detoxify bioactivated AFB 1 were characterized, and the significance of the GSTM1 genetic polymorphism assessed. Additionally, cytosols prepared from freshly isolated human lung cells were used to investigate the abilities of different cell types to conjugate AFB 1 -8,9-epoxides. 
Materials and methods

Chemicals
Chemicals were obtained as follows: generally labeled [ 3 H]AFB 1 (16.9 Ci/mmol; Ͼ99.2% purity) from Moravek Biochemicals (Brea, CA); generally labeled [ 3 H]trans-stilbene oxide (tSBO; 15 Ci/mmol; Ͼ99% purity) from American Radiolabeled Chemicals (St Louis, MO); glucose-6-phosphate, glucose-6-phosphate dehydrogenase, nicotinamide adenine dinucleotide phosphate (NADP), 1-chloro-2,4-dinitrobenzene (CDNB), ethylenediaminetetraacetic acid (EDTA), deoxyribonuclease (DNase) type I, protease type XIV, RPMI-1640 medium and trypsin inhibitor type II-S from Sigma (St Louis, MO); Percoll from Pharmacia (Dorval, PQ); bovine serum albumin and N-2-hydroxy-ethylpiperazine-N-2-ethanesulfonic acid (HEPES) from Boehringer Mannheim (Dorval, PQ); Taq polymerase, deoxynucleoside triphosphates, MgCl 2 and polymerase chain reaction (PCR) buffer from Gibco BRL, Life Technologies (Gaithersburg, MD). Authentic AFB 1 -GSH, used as a high-performance liquid chromatography (HPLC) standard, was generously provided by Dr Gordon E.Neal and Dr David J.Judah (MRC Laboratories, Surrey, UK). AFB 1 exo-epoxide-GSH standard, used for chiral HPLC analysis, was kindly supplied by Dr T.M.Harris (Vanderbilt University, Nashville, TN). All other chemicals were of reagent grade and were obtained from common commercial sources.
Animals and subcellular fractions
Male New Zealand white rabbits (2.0-2.5 kg), male Sprague-Dawley rats (250-300 g) and male CD-1 mice (25-30 g) were obtained from Charles River (LaPrairie, PQ). Animals were housed in individual cages on a 12 h light-dark cycle and fed Purina chow and water ad libitum. Animals were acclimatized to housing conditions for at least 1 week prior to experiments. Rats and mice were killed by decapitation, and rabbits received a single injection of sodium pentobarbital (78 mg/kg, 65 mg/ml) plus heparin (10 mg/kg, 50 mg/ml in saline) in a marginal ear vein. Liver microsomes and 100 000 g supernatants (cytosolic fractions) were prepared by differential centrifugation as described previously (21 informed consent, sections of peripheral lung tissue (46 Ϯ 18 g, mean Ϯ SD, n ϭ 10) devoid of macroscopically visible tumours, were removed during clinically indicated lobectomies. Immediately after removal, tissues were placed in 0.9% NaCl solution and stored on ice. Elapsed time between surgical removal of lung tissue and processing was~20 min. Lung specimens were rinsed of blood with ice-cold HEPES-buffered salt solution, weighed and sections removed for fixation and hematoxylin and eosin staining (22) to confirm the absence of microscopic tumours. Sections from each tissue were also removed and frozen in liquid nitrogen for DNA isolation and PCR analysis. Patients were characterized with respect to age, sex, smoking history, possible occupational exposure to carcinogens, drug treatment 1 month prior to surgery and surgical diagnosis (Table I) .
DNA isolation and GSTM1 genotyping DNA was isolated from lung tissue by proteinase digestion followed by phenolchloroform extraction and ethanol precipitation (23) . PCR amplification of GSTM1 was performed as described previously (24) and PCR products from coamplification of GSTM1 and the β-globin gene (positive control) were resolved on an ethidium-bromide-stained 3% agarose gel. Control DNA samples from GSTM1-positive and GSTM1-negative subjects were kindly provided by Dr D.A.Bell (National Institute of Environmental Health Sciences, Research Triangle Park, NC).
Preparation of human whole-lung cytosols
Whole-lung cytosols (100 000 g supernatants) were prepared by differential centrifugation as described previously (21) , frozen in liquid nitrogen and stored at -70°C for up to 2 months. Following thawing, cytosols were concentrated using an Amicon model 8050 stirred ultrafiltration cell with a 10 000 Da MW cut-off membrane, at 30 p.s.i. N 2 and 4°C. Cytosols were then dialyzed at 4°C for 22 h (12-14 kDa cut-off) against two changes of 1 l of 0.1 M potassium phosphate buffer (pH 7.4) containing 1.15% (w/v) KCl. Protein concentrations were determined by the method of Lowry et al. (25) .
Human lung cell isolation and preparation of cell cytosols
Human lung cells were isolated by a previously published method (26, 27) . Briefly, following protease digestion, an aliquot of the unseparated cell suspension (cell digest) was saved, and the remaining cells underwent centrifugal elutriation using a Beckman J2-21M/E centrifuge with a JE-6B elutriation rotor. Three elutriation fractions were collected: the first (E1) contained primarily red blood cells and cellular debris; the second (E2) contained large numbers of alveolar type II cells, an aliquot of which underwent further enrichment; and the third (E3) contained a high proportion of alveolar macrophages.
Alveolar type II cells were further enriched from E2 by Percoll density gradient centrifugation. Cells were layered on a 38% (v/v) Percoll solution in RPMI-1640 medium and centrifuged at 1000 g for 15 min. Alveolar type II cells remained at the top of the Percoll solution, and the bottom layer consisted largely of neutrophils and red blood cells.
Viability and yield of cells were estimated by trypan blue exclusion on a hemocytometer (28) . Using light microscopy, identification of alveolar type II cells was accomplished with the modified Papanicolaou method (29) , which stains phospholipid-containing cytoplasmic lamellar bodies; alveolar macrophages were identified by their large size, round cell shape and nucleus, and the absence of stained cytoplasmic granules. Cell fractions were frozen in liquid nitrogen and stored at -70°C prior to subsequent preparation of cytosols. Cell fractions were thawed, lyzed by sonication, and cytosols prepared using differential centrifugation with Beckman Ultra-Clear micro centrifuge tubes (8ϫ49 mm) as described previously (21, 30) .
[ 3 H]tSBO assay to determine GSTM1 phenotype [ 3 H]tSBO conjugation activities were measured as described (31) with some modifications. Each 100 µl reaction mixture contained 90 µl dialyzed wholelung cytosol diluted to 1-2 mg/ml with 0.1 M potassium phosphate buffer (pH 7.4), 5.0 µl GSH (final concentration, 5.0 mM) and 5 µl [ 3 H]tSBO (final concentration 50 µM, 64 µCi/µmol). Incubations were carried out for 30 min at 37°C, followed by centrifugation at 200 g for 15 min, addition of 400 µl hexanol and further centrifugation (200 g, 15 min). Aliquots of aqueous phase containing [ 3 H]tSBO-GSH were then removed for quantitation by liquid scintillation spectroscopy.
Measurement of CDNB conjugation activity in human whole-lung cytosols
GST-catalyzed conjugation of CDNB in human whole-lung cytosols was measured as described by Habig et al. (32) , with some modifications. CDNB (60 µl of 50 mM in absolute ethanol), 1 mg/ml human lung cytosol (60 µl in 0.1 M potassium phosphate buffer pH 6.5) and 50 mM GSH (60 µl in 0.1 M potassium phosphate buffer pH 6.5) were mixed with 0.1 M potassium phosphate buffer (pH 6.5) plus 0.1 M EDTA in a total volume of 3.0 ml, and absorbance measured at 340 nm for 3 min. 1 ,and incubated for 1 h for whole-lung cytosols or 2 h for lung cell cytosols. Control incubations without human lung cytosolic protein were carried out to assess non-human GST catalysis (i.e. contribution of membrane-bound GST present in rabbit liver microsomes, or potential contamination of microsomes with rabbit liver cytosol), and spontaneous reaction of AFB 1 -epoxides with GSH. Prior to determining the ability of human lung GSTs to conjugate the two AFB 1 -epoxide stereoisomers, it was necessary to confirm that the rabbit liver microsomal system used to generate the epoxides, produced similar amounts of AFB 1 exo and endo stereoisomers. Incubations were conducted as described above, except 2 mg rabbit liver microsomal protein were combined with mouse, rat or rabbit liver cytosol (1 and 10 mg protein each) and 100 µM [ 3 H]AFB 1 (70 µCi/µmol). Mouse liver cytosolic GSTs possess high activity towards AFB 1 exo-epoxide relative to AFB 1 endo-epoxide (12) , and though activity is considerably lower, rat liver cytosolic GSTs demonstrate stereospecificity for AFB 1 endo-epoxide (12) . We showed previously that rabbit liver cytosolic GSTs catalyze the GSH conjugation of both AFB 1 -epoxide isomers (33) . Reactions were terminated by addition of 2.0 ml ice-cold chloroform, followed by mixing. Incubates were then centrifuged at 200 g for 15 min at 4°C, and the aqueous layers removed for storage at -20°C until analysis by HPLC. (34) . A 250 µl aliquot of aqueous phase was eluted isocratically with mobile phase consisting of 30% methanol in distilled water and 0.03% acetic acid, at a flow rate of 1.5 ml/min, utilizing a Waters µBondapak C 18 column (3.9ϫ300 mm). Peaks were detected by absorbance at 365 nm with a Waters Model 481 LC spectrophotometer, and 1.0 ml fractions were collected using a Gilson 203 fraction collector. Quantitation of [ 3 H]AFB 1 -GSH conjugate was carried out by liquid scintillation spectoscopy, using a Beckman LS 3800 liquid scintillation counter and Fisher ScintiVerse BD scintillation cocktail. Identification of [ 3 H]AFB 1 -GSH was established by co-elution of authentic AFB 1 -GSH standard.
AFB 1 exo-and endo-epoxide-GSH conjugates were separated by a published method (35) , and stereoisomer identity determined as described previously (33) . GSTM1-negative patients and to assess smoking history effect on AFB 1 -GSH formation. Statistically significant differences were determined by repeated measures design one-way analysis of variance (ANOVA) for the isolated lung cell data, or two-way ANOVA with the whole-lung data, followed by the Tukey-Kramer multiple comparisons test. Pearson linear correlation was used to test the relationships between GST-catalyzed AFB 1 -GSH formation and percentage alveolar type II cells or percentage alveolar macrophages, and between CDNB conjugation and AFB 1 -GSH conjugation. A P-value less than 0.05 was considered statistically significant in all cases.
Statistical analysis
Results
Whole-lung cytosol experiments
Of the total of 14 patients, seven were GSTM1-positive and seven were GSTM1-negative (Table I ). Conjugation of [ 3 H]tSBO in whole-lung cytosols of GSTM1-positive individuals (295 Ϯ 31 pmol/mg/min; n ϭ 6) was~3-fold higher than in cytosols from GSTM1-negative individuals (92.8 Ϯ 23.3 pmol/mg/min; n ϭ 4, P Ͻ 0.05) (Figure 2) . [ 3 H]AFB 1 -epoxide conjugation also was not significantly different between current smokers (n ϭ 6) and non-smokers or former smokers (n ϭ 4, P Ͼ 0.05): current smokers 15.7 Ϯ 14.1, 165 Ϯ 177 and 534 Ϯ 480; non-smokers or former smokers 9.58 Ϯ 5.92, 84.3 Ϯ 58.0 and 503 Ϯ 315 (for 1.0, 10 and 100 µM [ 3 H]AFB 1 , respectively).
Rabbit liver microsomes generated AFB 1 exo-and endoepoxides in a ratio of~1:1. Chiral HPLC analysis of whole human lung cytosol incubations with 100 µM [ 3 H]AFB 1 bioactivated by rabbit liver microsomes showed that AFB 1 exoepoxide-GSH and AFB 1 endo-epoxide-GSH were produced in a ratio of~1:1 (data not shown).
CDNB conjugation activity was 0. (Figure 4 ) and was significantly different from all other isolated cell fractions (P Ͻ 0.05). Furthermore, a significant correlation was observed between AFB 1 -GSH formation and percentage of alveolar type II cells in different cell fractions (r ϭ 0.78, P Ͻ 0.05), with no significant correlation being found with percentage of alveolar macrophages r ϭ -0.16, P Ͼ 0.05) ( Figure 5 ). As in the case of whole lung, isolated cell cytosols produced [ 3 H]AFB 1 exoand endo-epoxide-GSH conjugate stereoisomers in a ratio of~1:1. Although the number of tissue samples used for cell isolation was small, the lack of association between [ 3 H]AFB 1 -GSH formation and GSTM1 genotype in whole-lung cytosols appeared to be supported by the isolated cell results in that no clear difference was apparent between the one GSTM1-positive (no. 12) and three GSTM1-negative patients (nos 11, 13 and 14) (Figure 4 ).
Discussion
Epidemiological and clinical studies suggest that the human respiratory system can be at risk of AFB 1 toxicity following both inhalation (2,4-6) and ingestion (7, 8) . We have shown previously that lipoxygenases and prostaglandin H-synthase activate AFB 1 via co-oxidation in human lung, with cytochrome P450-catalyzed oxidation a quantitatively much less important bioactivation pathway (27) . Other investigators have also found evidence showing very low levels of human lung microsomal bioactivation of AFB 1 (36) . Since GST-catalyzed conjugation of AFB 1 exo-and endo-epoxides with GSH is a critical detoxification pathway, the characterization and localization of human lung GSTs with respect to these electrophilic toxicants were the aims of the present work. Overall, human lung cytosol had very low AFB 1 -epoxide conjugating activity, with rabbit lung activity being~350-fold higher (33) .
Determining the ratio of AFB 1 -epoxides that are detoxified in a given tissue or cell has important toxicological implications, since only the exo-epoxide interacts significantly with DNA (9). Though not highly genotoxic, the endo-epoxide could conceivably contribute to acute toxicity by binding to critical cellular proteins. We showed previously that rabbit lung GSTs can detoxify AFB 1 exo-epoxide, but not AFB 1 endo-epoxide (33) . Thus, human lung differs from rabbit lung, since the former detoxified both AFB 1 -epoxides to their corresponding GSH conjugates to similar degrees, in both whole lung and isolated cell cytosols.
The cytosolic GST enzymes known to be present in human lung belong to three main classes, α, µ and π, which represent 30, 10 and 60% of total GST protein, and 3, 3 and 94% of total CDNB conjugation activity, respectively (37). The π-class GST, designated hGSTP1-1, exhibits negligible activity towards AFB 1 -epoxides (12, 13) . In the present study, the lack of correlation between CDNB conjugating activity and AFB 1 -GSH formation confirms the minimal contribution of hGSTP1-1 towards AFB 1 -epoxide detoxification in the human lung. The α-class subunits hGSTA1 and A2 have been detected in human lung (38) , and Singhal et al. (37) purified three α-class GST proteins from human lung tissue. Immunostaining of the α-class GSTs showed wide variability between individuals, both in intensity and distribution, with localization occurring in bronchial, bronchiolar and alveolar epithelium and in alveolar macrophages (18) . Purified hGSTA1-1 and hGSTA2-2 have measurable but low activity with AFB 1 exoand endo-epoxides as substrates (12), although experiments using recombinant hGSTA1-1 and hGSTA2-2 showed negligible activity toward AFB 1 exo-epoxide (13) . Thus, α-class GSTs may have been contributors to the low levels of AFB 1 -epoxide conjugation we observed.
In the case of the µ-class GSTs in human lung, all five known subunits have been detected: hGSTM1, M2, M3, M4 and M5 (38) (39) (40) . Immunohistochemical localization of three µ-class GSTs in human lung showed very low or absent GSTM1 in bronchial and bronchiolar epithelium, low levels of GSTM2 in the terminal bronchiolar epithelium and alveolar type II cells, and GSTM3 which varied between individuals from minimal to intense in bronchial and bronchiolar epithelium, bronchial glands and in bronchial and vascular smooth muscle (18) . The GSTM1 gene has attracted particular interest with respect to defense against chemical carcinogens. It is polymorphic in humans, with individuals possessing genetically-determined combinations of the GSTM10, M1a and M1b alleles [the 1a and 1b proteins differ only by one amino acid, and demonstrate similar catalytic properties (41)]. The deficiency in enzyme activity is caused by inherited homozygous deletion of the GSTM1 gene, which occurs with a frequency of~50% in most populations (42) .
Several studies with human liver have investigated the potential relationship between AFB 1 carcinogenicity and the GSTM1 polymorphism. Liver preparations from patients with high hGSTM1-1 activity inhibited the formation of AFB 1 -DNA adducts more than those from individuals with low hGSTM1-1 activity (15), and purified hGSTM1a-1a had the highest activity for AFB 1 -epoxides, relative to other human GSTs (hGSTA1-1, A2-2, M3-3 and P1-1) (12) . Furthermore, studies with recombinant human GSTs showed hGSTM1b-1b to catalyze the conjugation of AFB 1 exo-epoxide with greatest efficiency (13) . These results are consistent with the reported detection of AFB 1 -GSH in cultured primary hepatocytes from GSTM1-positive patients only (16) , but contradict the findings of Slone et al. (43) , who failed to find a correlation between immunochemically and enzymatically detected GSTµ expression and AFB 1 -epoxide conjugation in human liver cytosols. Our results show that hGSTM1-1 does not contribute signific-antly to the detoxification of AFB 1 -epoxides in human peripheral lung.
The most abundant µ-class GST throughout the conductive and peripheral human lung, hGSTM3-3, exhibits low activity for AFB 1 exo-and endo-epoxides (12) . Interestingly, a polymorphism in hGSTM3-3 has been discovered, but the activities of the different phenotypes (hGSTM3a-3a, M3b-3b and M3a-3b) have yet to be characterized (44) . Furthermore, data suggest that expression of GSTM3 is influenced by GSTM1 genotype, with GSTM1-negative individuals expressing significantly less GSTM3-3 than the other GSTM1 genotypes (45) . If GSTM3-3 expression and GSTM1 genotype are linked, and if GSTM3-3 is important in AFB 1 detoxification in human lung, then a correlation between GSTM1 genotype and AFB 1 -GSH formation in the present study would have been expected. However, this was not the case. The other known µ-class GSTs in human lung, hGSTM2-2, M4-4 and M5-5, may be important in detoxifying electrophilic carcinogens, but activities towards such substrates (including AFB 1 -epoxides) are currently unknown.
Our observed lack of correlation between AFB 1 -epoxide conjugation and smoking history is consistent with the previously reported lack of difference in immunoreactivity for several GSTs (45) and CDNB conjugating activity (46) in human lung tissue from smokers versus non-smokers.
Cytosolic GSTs in alveolar type II cells had higher activity for conjugating bioactivated AFB 1 than did other cell fractions. Some studies have shown the presence of α-class and π-class GSTs in type II cells (18) , but these enzymes display low or undetectable conjugating activity with AFB 1 -epoxides (12, 13) , suggesting that the activity found in this cell type is due to the concentration of GST isoforms with relatively low activity for AFB 1 epoxides. Alveolar type II cells represent~16% of the cells of human lung (47) , and demonstrate relatively high biotransformation activities compared with other human lung cell types (18, 26, 48, 49) . Although CYP3A4 can bioactivate AFB 1 and is present in type II cells, we demonstrated previously that activation of AFB 1 to AFB 1 exo-epoxide occurs predominantly via prostaglandin H synthase and lipoxygenase co-oxidation in both alveolar type II cells and alveolar macrophages (27) . The present study showed that AFB 1 exoand endo-epoxide conjugating activity occurs at low levels in alveolar macrophages, which possess the α-class GSTs, hGSTP1-1, hGSTM3-3 and hGSTM1-1 (18, 20) . Thus, cytosolic GSTs affect the activation/detoxification balance such that detoxification is favoured more in type II cells than in macrophages. This is consistent with our earlier finding that, following in vitro exposure of intact human lung cells to AFB 1 , levels of AFB 1 -DNA binding were significantly higher in macrophages than in type II cells.
The θ-class hGSTT1-1, which is also polymorphic (50), has AFB 1 exo-epoxide conjugating activity which is less than that of hGSTM1-1, but greater than that of hGSTP1-1 and the α-class GSTs (13) . Low levels of hGSTT1-1 mRNA have been found in some human lung samples (51), but it is expressed at higher levels in red blood cells. Therefore, if hGSTT1-1 contributes appreciably to AFB 1 detoxification in the lung, AFB 1 -GSH formation should have been high in the cell fraction with the highest concentration of erythrocytes, elutriation fraction E1. However, this was not the case.
In conclusion, human lung possesses very low conjugation activity for both AFB 1 -8,9-epoxide stereoisomers, and this activity is heterogeneously distributed among cell types. Contri-butions of several GSTs, including those of the α-class and µ-class other than hGSTM1-1, probably account for the conjugation activity present. The human lung may be at risk of AFB 1 toxicity due to its limited ability to conjugate AFB 1 -epoxides with GSH.
